HK Stock MarketDetailed Quotes

HAOHAI BIOTEC (06826)

Watchlist
  • 22.160
  • +0.180+0.82%
Noon Break May 7 11:41 CST
5.10BMarket Cap19.20P/E (TTM)

HAOHAI BIOTEC (06826) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
-7.62%571.44M
-8.71%2.45B
-8.47%1.9B
-7.48%1.29B
-4.25%618.54M
1.70%2.68B
4.69%2.07B
7.00%1.4B
5.68%646M
25.27%2.63B
Operating income
-7.62%571.44M
-8.71%2.45B
-8.47%1.9B
-7.48%1.29B
-4.25%618.54M
1.70%2.68B
4.69%2.07B
7.00%1.4B
5.68%646M
25.27%2.63B
Cost of sales
----
9.39%-734.73M
----
6.63%-386.36M
----
-3.77%-810.88M
----
-9.10%-413.82M
----
-19.02%-781.4M
Operating expenses
-2.09%-192.47M
9.39%-734.73M
8.38%-562.36M
6.63%-386.36M
5.20%-188.52M
-3.77%-810.88M
-9.24%-613.79M
-9.10%-413.82M
-14.13%-198.87M
-19.02%-781.4M
Gross profit
-11.87%378.97M
-8.41%1.71B
-8.51%1.34B
-7.83%906.28M
-3.83%430.02M
0.82%1.87B
2.90%1.46B
6.14%983.3M
2.32%447.12M
28.10%1.85B
Selling expenses
16.49%-161.92M
-4.35%-814.82M
-1.02%-600.54M
3.18%-392.38M
2.74%-193.89M
4.13%-780.85M
4.98%-594.49M
3.72%-405.27M
0.51%-199.35M
-19.86%-814.51M
Administrative expenses
3.25%-85.36M
3.11%-433.07M
0.52%-323.56M
1.90%-206.19M
-6.99%-88.23M
-5.83%-446.98M
-3.76%-325.24M
-4.76%-210.19M
11.94%-82.47M
-4.20%-422.35M
Research and development expenses
-7.37%-51.99M
17.22%-197.78M
20.75%-149.1M
21.53%-98.4M
25.40%-48.42M
-8.56%-238.93M
-22.04%-188.14M
-23.68%-125.4M
-21.03%-64.9M
-20.81%-220.1M
Profit from asset sales
-94.83%18.59K
----
-91.37%18.82K
----
1,089.78%359.5K
----
-57.97%217.99K
----
-9,233.48%-36.32K
----
Revaluation surplus
231.77%391.1K
----
143.11%148.89K
----
125.57%117.88K
----
-116.05%-345.33K
----
-182.99%-461.1K
----
-Changes in the fair value of other assets
231.77%391.1K
----
143.11%148.89K
----
125.57%117.88K
----
-116.05%-345.33K
----
-182.99%-461.1K
----
Impairment and provision
53.55%-3.05M
-307.27%-4.62M
-19.94%-15.38M
-557.93%-2.17M
-7,479.64%-6.57M
12.98%2.23M
-69.47%-12.83M
110.30%473K
103.74%89.04K
112.72%1.97M
-Other impairment is provision
53.55%-3.05M
-307.27%-4.62M
-19.94%-15.38M
-557.93%-2.17M
-7,479.64%-6.57M
12.98%2.23M
-69.47%-12.83M
110.30%473K
103.74%89.04K
112.72%1.97M
Special items of operating profit
650.59%17.68M
-104.02%-3.18M
70.08%42.92M
27.79%34.26M
-39.08%2.36M
-32.27%78.96M
-10.17%25.23M
-50.63%26.81M
-63.44%3.87M
54.51%116.57M
Operating profit
-3.09%90.7M
-46.58%258.11M
-20.92%279.51M
-10.50%241.39M
-7.02%93.6M
-6.19%483.22M
3.76%353.45M
6.54%269.71M
5.05%100.66M
121.81%515.1M
Financing income
-17.56%11.27M
----
-5.51%51.86M
----
-23.59%13.67M
----
-4.76%54.88M
----
-6.77%17.89M
----
Financing cost
8.93%-2.3M
-4.52%-18.88M
6.75%-8.37M
24.25%-5.7M
5.61%-2.52M
-147.58%-18.06M
-96.82%-8.98M
-104.87%-7.52M
-154.05%-2.67M
---7.3M
Share of profits of associates
----
-98.99%10K
----
-120.33%-62K
----
116.23%986K
----
-6.44%305K
----
51.50%456K
Special items of earning before tax
79.58%-97.9K
----
1,897.84%19.61M
----
-82.44%-479.55K
----
-246.17%-1.09M
----
-131.68%-262.85K
----
Earning before tax
-6.84%96.26M
-48.68%239.25M
-10.59%345.5M
-10.23%235.63M
-9.49%103.33M
-8.29%466.15M
-0.75%386.44M
5.08%262.49M
1.85%114.16M
115.61%508.26M
Tax
----
65.60%-30.92M
----
24.24%-33.97M
----
6.34%-89.9M
----
-9.06%-44.83M
----
-111.46%-95.99M
After-tax profit from continuing operations
-14.50%71.66M
-44.63%208.32M
-6.81%294.47M
-7.35%201.67M
-9.38%83.81M
-8.74%376.24M
-3.36%315.98M
4.30%217.66M
8.87%92.49M
116.61%412.27M
Earning after tax
-14.50%71.66M
-44.63%208.32M
-6.81%294.47M
-7.35%201.67M
-9.38%83.81M
-8.74%376.24M
-3.36%315.98M
4.30%217.66M
8.87%92.49M
116.61%412.27M
Minority profit
70.79%-1.9M
3.43%-42.69M
59.14%-10.18M
46.67%-9.4M
-28.67%-6.5M
-1,047.56%-44.2M
-15,245.51%-24.91M
-610.57%-17.63M
-233.88%-5.05M
-139.06%-3.85M
Profit attributable to shareholders
-18.55%73.56M
-40.30%251.01M
-10.63%304.65M
-10.29%211.07M
-7.41%90.31M
1.04%420.45M
4.31%340.89M
14.64%235.28M
20.16%97.54M
130.58%416.12M
Basic earnings per share
-17.95%0.32
-40.00%1.08
-10.27%1.31
-9.90%0.91
-7.14%0.39
2.86%1.8
6.57%1.46
17.44%1.01
-10.64%0.42
68.27%1.75
Diluted earnings per share
-17.95%0.32
-40.00%1.08
-10.27%1.31
-9.90%0.91
-7.14%0.39
2.86%1.8
6.57%1.46
17.44%1.01
-10.64%0.42
68.27%1.75
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
--
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover -7.62%571.44M-8.71%2.45B-8.47%1.9B-7.48%1.29B-4.25%618.54M1.70%2.68B4.69%2.07B7.00%1.4B5.68%646M25.27%2.63B
Operating income -7.62%571.44M-8.71%2.45B-8.47%1.9B-7.48%1.29B-4.25%618.54M1.70%2.68B4.69%2.07B7.00%1.4B5.68%646M25.27%2.63B
Cost of sales ----9.39%-734.73M----6.63%-386.36M-----3.77%-810.88M-----9.10%-413.82M-----19.02%-781.4M
Operating expenses -2.09%-192.47M9.39%-734.73M8.38%-562.36M6.63%-386.36M5.20%-188.52M-3.77%-810.88M-9.24%-613.79M-9.10%-413.82M-14.13%-198.87M-19.02%-781.4M
Gross profit -11.87%378.97M-8.41%1.71B-8.51%1.34B-7.83%906.28M-3.83%430.02M0.82%1.87B2.90%1.46B6.14%983.3M2.32%447.12M28.10%1.85B
Selling expenses 16.49%-161.92M-4.35%-814.82M-1.02%-600.54M3.18%-392.38M2.74%-193.89M4.13%-780.85M4.98%-594.49M3.72%-405.27M0.51%-199.35M-19.86%-814.51M
Administrative expenses 3.25%-85.36M3.11%-433.07M0.52%-323.56M1.90%-206.19M-6.99%-88.23M-5.83%-446.98M-3.76%-325.24M-4.76%-210.19M11.94%-82.47M-4.20%-422.35M
Research and development expenses -7.37%-51.99M17.22%-197.78M20.75%-149.1M21.53%-98.4M25.40%-48.42M-8.56%-238.93M-22.04%-188.14M-23.68%-125.4M-21.03%-64.9M-20.81%-220.1M
Profit from asset sales -94.83%18.59K-----91.37%18.82K----1,089.78%359.5K-----57.97%217.99K-----9,233.48%-36.32K----
Revaluation surplus 231.77%391.1K----143.11%148.89K----125.57%117.88K-----116.05%-345.33K-----182.99%-461.1K----
-Changes in the fair value of other assets 231.77%391.1K----143.11%148.89K----125.57%117.88K-----116.05%-345.33K-----182.99%-461.1K----
Impairment and provision 53.55%-3.05M-307.27%-4.62M-19.94%-15.38M-557.93%-2.17M-7,479.64%-6.57M12.98%2.23M-69.47%-12.83M110.30%473K103.74%89.04K112.72%1.97M
-Other impairment is provision 53.55%-3.05M-307.27%-4.62M-19.94%-15.38M-557.93%-2.17M-7,479.64%-6.57M12.98%2.23M-69.47%-12.83M110.30%473K103.74%89.04K112.72%1.97M
Special items of operating profit 650.59%17.68M-104.02%-3.18M70.08%42.92M27.79%34.26M-39.08%2.36M-32.27%78.96M-10.17%25.23M-50.63%26.81M-63.44%3.87M54.51%116.57M
Operating profit -3.09%90.7M-46.58%258.11M-20.92%279.51M-10.50%241.39M-7.02%93.6M-6.19%483.22M3.76%353.45M6.54%269.71M5.05%100.66M121.81%515.1M
Financing income -17.56%11.27M-----5.51%51.86M-----23.59%13.67M-----4.76%54.88M-----6.77%17.89M----
Financing cost 8.93%-2.3M-4.52%-18.88M6.75%-8.37M24.25%-5.7M5.61%-2.52M-147.58%-18.06M-96.82%-8.98M-104.87%-7.52M-154.05%-2.67M---7.3M
Share of profits of associates -----98.99%10K-----120.33%-62K----116.23%986K-----6.44%305K----51.50%456K
Special items of earning before tax 79.58%-97.9K----1,897.84%19.61M-----82.44%-479.55K-----246.17%-1.09M-----131.68%-262.85K----
Earning before tax -6.84%96.26M-48.68%239.25M-10.59%345.5M-10.23%235.63M-9.49%103.33M-8.29%466.15M-0.75%386.44M5.08%262.49M1.85%114.16M115.61%508.26M
Tax ----65.60%-30.92M----24.24%-33.97M----6.34%-89.9M-----9.06%-44.83M-----111.46%-95.99M
After-tax profit from continuing operations -14.50%71.66M-44.63%208.32M-6.81%294.47M-7.35%201.67M-9.38%83.81M-8.74%376.24M-3.36%315.98M4.30%217.66M8.87%92.49M116.61%412.27M
Earning after tax -14.50%71.66M-44.63%208.32M-6.81%294.47M-7.35%201.67M-9.38%83.81M-8.74%376.24M-3.36%315.98M4.30%217.66M8.87%92.49M116.61%412.27M
Minority profit 70.79%-1.9M3.43%-42.69M59.14%-10.18M46.67%-9.4M-28.67%-6.5M-1,047.56%-44.2M-15,245.51%-24.91M-610.57%-17.63M-233.88%-5.05M-139.06%-3.85M
Profit attributable to shareholders -18.55%73.56M-40.30%251.01M-10.63%304.65M-10.29%211.07M-7.41%90.31M1.04%420.45M4.31%340.89M14.64%235.28M20.16%97.54M130.58%416.12M
Basic earnings per share -17.95%0.32-40.00%1.08-10.27%1.31-9.90%0.91-7.14%0.392.86%1.86.57%1.4617.44%1.01-10.64%0.4268.27%1.75
Diluted earnings per share -17.95%0.32-40.00%1.08-10.27%1.31-9.90%0.91-7.14%0.392.86%1.86.57%1.4617.44%1.01-10.64%0.4268.27%1.75
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions ----------Unqualified Opinion------Unqualified Opinion
Auditor ----------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More